Is Teladoc Health Headed for a Big Move?

This post was originally published on this site

Demand for TDOC’s offerings have been decreasing this year after a surge in demand last year. Even as the Delta variant soared across the country, doctor’s started seeing patients in the office again. The company’s 2021 guidance for membership and visit growth is now lower than last year’s.

As of the most recent quarter the company had $786 million in cash, which compared favorably to no short-term debt. In terms of growth, TDOC’s earnings are expected to fall 48.8% year over year in the current quarter.

Continue reading on StockNews